One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-128302
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 9 |
Affiliation: Hokkaido University Hospital, Toranomon Hospital, Hamilton Health Sciences, University of Würzburg, University of Minnesota, Cornell University, Tris Pharma (United States), Medical University of Vienna, Vienna General Hospital, Peter MacCallum Cancer Centre, Oslo Cancer Cluster, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Oregon Health & Science University, Novartis (Switzerland), Emory University, Hospices Civils de Lyon, Hôpital Lyon Sud, James Cancer Hospital, The Ohio State University, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, University Hospital Cologne, University of Kansas Medical Center, Hôpital Maisonneuve-Rosemont, Université de Montréal, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Royal Prince Alfred Hospital, University of Amsterdam, Academic Medical Center, Kyushu University Hospital, University of Pennsylvania, UPMC Hillman Cancer Center, University of Michigan–Ann Arbor, University of Chicago
Impact of Tisagenlecleucel Chimeric Antigen Receptor (CAR)-T Cell Therapy Product Attributes on Clinical Outcomes in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
